IRVINE, Calif.--(BUSINESS WIRE)--Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against USANA Health Sciences, Inc. (“USANA” or the “Company”) (NYSE: USNA) concerning possible violations of federal securities laws. Investors, who purchased or otherwise acquired shares between March 14, 2014 and February 7, 2017 inclusive (the "Class Period"), are encouraged to contact the Firm in advance of the April 14, 2017 lead plaintiff motion deadline.
If you purchased shares of USANA during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at firstname.lastname@example.org.
There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.
USANA develops, manufactures and sells nutritional and personal care products primarily to reduce the risk of chronic degenerative disease.
On February 7, 2017, USANA revealed that it will be starting an internal investigation of its Chinese subsidiary, BabyCare Ltd. (“BabyCare”).
In particular, the Company’s investigation concerns “compliance with the Foreign Corrupt Practices Act” as well as “BabyCare’s expense reimbursement policies.”
When this information was revealed to the investing public, the value of USANA declined, causing investors harm.
If you wish to learn more about this lawsuit at no charge, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at email@example.com.
This press release may constitute Attorney Advertising in some jurisdictions.